MHRA OK for Almac’s Durham distribution center.

By Gareth Macdonald

- Last updated on GMT

Related tags Almac Food and drug administration Pharmacology

The MHRA has renewed its approval of Almac’s facility in North Carolina, bringing an end to a busy and successful four months of inspections at the clinical services group’s facilities.

The Medicines and Healthcare products Regulatory Agency (MHRA), which was asked by Almac to conduct the inspection, confirmed that the Durham facility fully complies with all European Union good manufacturing practice (GMP) rules.

Almac’s North Carolina facility, which is located in the Southern city of Durham, is the hub of the firm’s packaging and distribution operations for both candidate drug products and clinical trial supplies shipped around the world.

With the continued growth of clinical trial services in China and India, companies like Almac are keen to emphasise the quality of their offerings and focus on gaining approval from regulators worldwide in order to maintain a market advantage.

The MHRA decision completes the clean sweep of approvals gained by Almac facilities in Craigavon in the UK and Audubon, Pennsylvania, adding to similar GMP status issued by the US Food and Drug Administration (FDA).

Paul O’Connor, Almac’s global head of quality for clinical trial services, told in-PharmaTechnologist that while both Durham and Audubon are outside the firm’s jurisdiction, it believes “the clean bill of health will provide further reassurance for customers​”.

He explained that: “For clients, drug candidates are their baby and they often have only one chance to conduct trials. Our part is to receive [the] package and distributein a manner that complies with the rules governing trials and therefore welcome the chance to emphasise the quality of our service​.”

O’Connor also said that MHRA approval for its US facilities was a distinct advantage for Almac as it would help its customers gain the qualified person clearance that is required for all clinical trial materials used in Europe.

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars